Next Article in Journal
A COVID-19 DNA Vaccine Candidate Elicits Broadly Neutralizing Antibodies against Multiple SARS-CoV-2 Variants including the Currently Circulating Omicron BA.5, BF.7, BQ.1 and XBB
Next Article in Special Issue
Risk of Testing Positive for COVID-19 among Healthcare and Healthcare-Related Workers
Previous Article in Journal
Codon Pair Deoptimization (CPD)-Attenuated PRRSV-1 Vaccination Exhibit Immunity to Virulent PRRSV Challenge in Pigs
Previous Article in Special Issue
Investigating the Reasons for Receiving the Second Booster Dose of the COVID-19 Vaccine in Adults and in People with Chronic Medical Conditions in Southern Italy
 
 
Article

Article Versions Notes

Vaccines 2023, 11(4), 779; https://doi.org/10.3390/vaccines11040779
Action Date Notes Link
article pdf uploaded. 31 March 2023 15:16 CEST Version of Record https://www.mdpi.com/2076-393X/11/4/779/pdf-vor
article xml uploaded. 3 April 2023 09:35 CEST Original file -
article pdf uploaded. 3 April 2023 09:35 CEST Updated version of record https://www.mdpi.com/2076-393X/11/4/779/pdf-vor
article html file updated 3 April 2023 09:36 CEST Original file -
article xml uploaded. 3 April 2023 11:17 CEST Update https://www.mdpi.com/2076-393X/11/4/779/xml
article pdf uploaded. 3 April 2023 11:17 CEST Updated version of record https://www.mdpi.com/2076-393X/11/4/779/pdf
article html file updated 3 April 2023 11:19 CEST Update -
article html file updated 3 April 2023 11:19 CEST Update -
article html file updated 7 April 2023 00:12 CEST Update https://www.mdpi.com/2076-393X/11/4/779/html
Back to TopTop